In the older (≥ 65 years) group, LAA thrombus prevalence was also lower in patients receiving NOAC (6.6%) compared to VKA-treated patients (9.4%), although the difference did not reach statistical significance, possibly due to the smaller sample size but perhaps also due to substantially increased thrombotic risk in the older group.
← all excerpts
Risk of left atrial appendage thrombus in older patients with atrial fibrillation.
1
—
—